Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

about

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

Item

http://www.wikidata.org/entity/Q49450264

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@en

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@nl

type

Item

label

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@en

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@nl

prefLabel

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@en

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@nl

P1476

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.

@en

P2093

Bin Li

http://www.w3.org/2001/XMLSchema#string

James S Martin

http://www.w3.org/2001/XMLSchema#string

Michael T Tetzlaff

http://www.w3.org/2001/XMLSchema#string

Pengxiang Li

http://www.w3.org/2001/XMLSchema#string

Ravi Amaravadi

http://www.w3.org/2001/XMLSchema#string

Ruifeng Yang

http://www.w3.org/2001/XMLSchema#string

Shujing Liu

http://www.w3.org/2001/XMLSchema#string

Suresh M Kumar

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

Xiang Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Mouse xenograft models vs GEM models for human cancer therapeutics

Tumor angiogenesis: therapeutic implications

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

HIF1α and HIF2α independently activate SRC to promote melanoma metastases

A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.

Cancer statistics, 2000.

P304

115140-115152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22944

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meenhard Herlyn

Adina Vultur

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29383148

http://www.w3.org/2001/XMLSchema#string

P932

5777760

http://www.w3.org/2001/XMLSchema#string